Population Pharmacokinetics of Patritumab Deruxtecan in Patients With Solid Tumors

Lu, YS; Shimizu, S; Sawamura, R; Tajima, N; He, L; Lee, M; Abutarif, M; Shi, R

Lu, YS (通讯作者),Daiichi Sankyo Inc, 211 Mt Airy Rd, Basking Ridge, NJ 07920 USA.

JOURNAL OF CLINICAL PHARMACOLOGY, 2023; 63 (1): 77

Abstract

Patritumab deruxtecan is an antibody-drug conjugate consisting of a fully human monoclonal antibody against human epidermal growth factor receptor 3 (......

Full Text Link